Targeting of poly( l -lysine) to organs that propagate prions

Abstract

Poly(l-lysine) was recently discovered to inhibit prion propagation. To develop poly(l-lysine) as a potential therapeutic for prion diseases, the understanding of in vivo poly(l-lysine) behavior is pivotal. Therefore, to determine the poly(l-lysine) distribution in mouse spleen and brain, the primary and ultimate target organs for prions, we performed non-invasive longitudinal in vivo imaging and time course on live mice and ex vivo imaging on mouse organs to confirmed poly(l-lysine) was distributed, including the brain and spleen. By studying the in vivo and ex vivo fluorescence images, characteristic patterns of poly(l-lysine) accumulation and elimination depending on different administration routes were also found. Although only a portion of the administered poly(l-lysine) appears to target the brain and spleen, the specific poly(l-lysine) level in these organs was higher than that previously reported. Furthermore, the poly(l-lysine) retention in the brain and spleen was greater than that found in other organs. These results provide valuable information about poly(l-lysine) behavior in vivo, which will be an aid in designing optimal regimens for potential application of poly(l-lysine) in anti-prion therapeutics.

Keywords

Polylysine targeting organ in vivo ex vivo bio-fluorescence imaging

Get full access to this article

View all access options for this article.

References

Yavin

. Attachment and culture of dissociated cells from rat embryo cerebral hemispheres on polylysine-coated surface. J Cell Biol 1974; 62: 540–546.

Letourneau

. Possible roles for cell-to-substratum adhesion in neuronal morphogenesis. Dev Biol 1975; 44: 77–91.

Wei

Y-T

Sun

X-D

Xia

. Hyaluronic acid hydrogel modified with Nogo-66 receptor antibody and poly(l-lysine) enhancement of adherence and survival of primary hippocampal neurons. J Bioact Compat Polym 2009; 24: 205–219.

Ren

Y-J

Zhou

Z-Y

Cui

F-Z

. Hyaluronic acid/polylysine hydrogel as a transfer system for transplantation of neural stem cells. J Bioact Compat Polym 2009; 24: 56–62.

Sakharov

Jie

AFH

Bekkers

MEA

. Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall. Arterioscler Thromb Vasc Biol 2001; 21: 943–948.

Arnold

LJJ

Dagan

Gutheil

. Antineoplastic activity of poly(l-lysine) with some ascites tumor cells. Proc Natl Acad Sci U S A 1979; 76: 3246–3250.

Langeland

Moore

Holmsen

. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J Gen Virol 1988; 69: 1137–1145.

Delihas

Reiley

Loo

. High sensitivity of mycobacterium species to the bactericidal activity by polylysine. FEMS Microbiol Lett 1995; 132: 233–237.

Ryou

Titlow

Mays

. The suppression of prion propagation using poly-l-lysine by targeting plasminogen that stimulates prion protein conversion. Biomaterials 2011; 32: 3141–3149.

10.

Jackson

Yeom

Han

. Preference toward a polylysine enantiomer in inhibiting prions. Amino Acids 2013; 44: 993–1000.

11.

Mays

Ryou

. Plasminogen stimulates propagation of protease-resistant prion protein in vitro. FASEB J 2010; 24: 5102–5112.

12.

Adrover

Pastore

. Mechanistic insights into cellular alteration of prion by poly-d-lysine: the role of H2H3 domain. FASEB J 2011; 25: 3426–3435.

13.

Titlow

Lee

Ryou

. Characterization of toxicological properties of l-lysine polymers in CD-1 mice. J Microbiol Biotechnol 2013; 23: 1015–1022.

14.

Florence

Sakthivel

Toth

. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J Control Release 2000; 65: 253–259.

15.

Ward

Read

Seymour

. Systemic circulation of poly(l-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 2001; 97: 2221–2229.

16.

Johnston

Kuchimanchi

Alur

. Inducing a change in the pharmacokinetics and biodistribution of poly-l-lysine in rats by complexation with heparin. J Pharm Pharmacol 2003; 55: 1083–1090.

17.

Ziady

A-G

Gedeon

Miller

. Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles in vivo. Mol Ther 2003; 8: 936–947.

18.

Okuda

Kawakami

Maeie

. Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. J Control Release 2006; 114: 69–77.

19.

Boyd

Kaminskas

Karellas

. Cationic poly-l-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats. Mol Pharm 2006; 3: 614–627.

20.

Kaminskas

Boyd

Karellas

. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. Mol Pharm 2008; 5: 449–463.

21.

Kimberlin

Walker

. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J Comp Pathol 1979; 89: 551–562.

22.

Rubenstein

Merz

Kascsak

. Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins. J Infect Dis 1991; 164: 29–35.

23.

Leblond

Davis

Valdés

. Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications. J Photochem Photobiol B 2010; 98: 77–94.

24.

Bickel

Yoshikawa

Pardridge

. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 2001; 46: 247–279.

25.

Yavin

. Synaptogenesis and myelinogenesis in dissociated cerebral cells from rat embryo on polylysine coated surfaces. Exp Brain Res 1977; 29: 137–147.

26.

Yaroslavov

Kuchenkova

Okuneva

. Effect of polylysine on transformations and permeability of negative vesicular membranes. Biochim Biophys Acta 2003; 1611: 44–54.

27.

Walsh

Tangney

O’Neill

. Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-l-lysine compacted DNA: implications for cancer gene therapy. Mol Pharm 2006; 3: 644–653.

28.

Wrighton

Stevens

. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992; 22: 1–21.

29.

Cherry

. Multimodality in vivo imaging systems: twice the power or double the trouble? Annu Rev Biomed Eng 2006; 8: 35–62.